Disulfiram
Disulfiram, an approved medication for the treatment of alcohol dependence, has been reported to inhibit MERS and SARS papain-like protease in cell cultures but there is no clinical evidence of it. However, it is debatable, whether HIV protease inhibitors could effectively inhibit the 3-chymotrypsin-like, as well as, papain-like proteases of 2019-nCoV, although, Disulfiram could possibly be screened against 2019-nCoV by facilities that have sufficient capabilities of bio-containment [37][47].9-nCoV / SARS-CoV-2 outbreak.